- Home
- LNTH vs NSIT Comparison
LNTH vs NSIT Comparison
Compare LNTH & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- NSIT
- Stock Information
- Founded
- LNTH 1956
- NSIT 1988
- Country
- LNTH United States
- NSIT United States
- Employees
- LNTH N/A
- NSIT N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- NSIT EDP Services
- Sector
- LNTH Health Care
- NSIT Technology
- Exchange
- LNTH Nasdaq
- NSIT Nasdaq
- Market Cap
- LNTH 3.6B
- NSIT 3.7B
- IPO Year
- LNTH 2015
- NSIT 1995
- Fundamental
- Price
- LNTH $52.99
- NSIT $123.69
- Analyst Decision
- LNTH Strong Buy
- NSIT Buy
- Analyst Count
- LNTH 5
- NSIT 3
- Target Price
- LNTH $91.60
- NSIT $183.00
- AVG Volume (30 Days)
- LNTH 1.6M
- NSIT 325.5K
- Earning Date
- LNTH 11-05-2025
- NSIT 10-30-2025
- Dividend Yield
- LNTH N/A
- NSIT N/A
- EPS Growth
- LNTH N/A
- NSIT N/A
- EPS
- LNTH 3.77
- NSIT 4.21
- Revenue
- LNTH $1,520,653,000.00
- NSIT $8,355,589,000.00
- Revenue This Year
- LNTH N/A
- NSIT $0.34
- Revenue Next Year
- LNTH $3.24
- NSIT $4.83
- P/E Ratio
- LNTH $14.58
- NSIT $30.72
- Revenue Growth
- LNTH 5.75
- NSIT N/A
- 52 Week Low
- LNTH $47.25
- NSIT $115.68
- 52 Week High
- LNTH $118.21
- NSIT $225.38
- Technical
- Relative Strength Index (RSI)
- LNTH 38.84
- NSIT 42.31
- Support Level
- LNTH $51.94
- NSIT $123.87
- Resistance Level
- LNTH $55.24
- NSIT $129.54
- Average True Range (ATR)
- LNTH 1.97
- NSIT 3.63
- MACD
- LNTH 0.48
- NSIT -0.05
- Stochastic Oscillator
- LNTH 15.34
- NSIT 7.67
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.